Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Registers $150.4M in Employee Stock Options

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe has filed for the registration of up to $150.4 million in additional shares in connection to a stock option being offered to all its employees.

According to the Form S-8 filed with the US Securities and Exchange Commission on Wednesday, the San Diego molecular diagnostics firm is registering 2.5 million shares at $60.14 per share. The price per share and aggregate offering price are based on the average high and low sales prices of gen-Probe's common stock on July 29.

Michael Watts, a spokesman for Gen-Probe, said the stock option plan was approved in May at the company's annual meeting.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.